Sight Sciences (SGHT) EBT Growth (3y) (2023 - 2026)
Sight Sciences (SGHT) EBT Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -2.34% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 20.27% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 35.51% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 23.63% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 25.85% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 6.73% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 89.20% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 17.92% |
| 10 | Sight Sciences | 445.31 Mn | 365.56 Mn | 21.37 Mn | 33.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.09% |
| Mar 31, 2026 | 8.72% |
| Dec 31, 2025 | 37.36% |
| Sep 30, 2025 | 28.12% |
| Jun 30, 2025 | 20.67% |
| Mar 31, 2025 | 15.33% |
| Dec 31, 2024 | 9.32% |
| Sep 30, 2024 | 14.03% |
| Jun 30, 2024 | 11.21% |
| Mar 31, 2024 | -10.06% |
| Dec 31, 2023 | -5.53% |
| Sep 30, 2023 | -17.00% |
| Jun 30, 2023 | -21.07% |